Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00796809 · ClinicalTrials.gov registry record
Risk of Coccidioidomycosis in Patients Receiving Anti-TNF and Other Biologic Agents for an Inflammatory Arthritis
A clinical trial of Rheumatoid Arthritis and Coccidioidomycosis, sponsored by University of Arizona.
- Completed
- Registry status
- 598
- Enrollment target
- 1
- Study location
NCT00796809 is a study of Rheumatoid Arthritis and Coccidioidomycosis that has completed, run by University of Arizona. The registered enrollment target is 598 participants, below the 4,688-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00796809, a study of Rheumatoid Arthritis and Coccidioidomycosis, has completed, sponsored by University of Arizona.
- COMPLETED
- Registry status
- 598 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of the project is to study the risk of coccidioidomycosis (valley fever) in patients receiving anti-TNF and other biologic agents for inflammatory arthritis in Tucson, Arizona.
Conditions Studied
Study Locations (1)
Arizona
- University of Arizona - Arizona Arthritis Center - Tucson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 598 participants |
| Start Date | 2007-10 |
| Est. Completion | 2008-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00796809
The ClinicalTrials.gov registry entry for NCT00796809 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 598 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,688-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (87% lower). The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 0 interventions.
NCT00796809 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.
Frequently Asked Questions
What is clinical trial NCT00796809 about?
NCT00796809 is a clinical study titled "Risk of Coccidioidomycosis in Patients Receiving Anti-TNF and Other Biologic Agents for an Inflammatory Arthritis". The goal of the project is to study the risk of coccidioidomycosis (valley fever) in patients receiving anti-TNF and other biologic agents for inflammatory arthritis in Tucson, Arizona.
What is the current status of trial NCT00796809?
This trial is currently completed. The enrollment target is 598 participants. The study started on 2007-10. Estimated completion is 2008-10.
What conditions does trial NCT00796809 study?
This clinical trial studies the following conditions: Rheumatoid Arthritis, Coccidioidomycosis.
Who is sponsoring clinical trial NCT00796809?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00796809 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rheumatoid Arthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Rheumatology Diet Study
RECRUITING
-
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
RECRUITING · Phase 1
-
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
RECRUITING · NA
-
Creating Health Course Study for People With Rheumatological Conditions
RECRUITING · NA
-
Physica System Total Knee Replacement Registry Study
RECRUITING · NA
-
Study of GS-0151 in Participants With Rheumatoid Arthritis
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.